The Underling Mechanisms Exploration of Rubia cordifolia L. Extract Against Rheumatoid Arthritis by Integrating Network Pharmacology and Metabolomics
Weiya Zeng,Yuan Fang,Suifen Mo,Caihong Shen,Huiling Yang,Guihua Luo,Luhua Xiao,Ruoting Zhan,Ping Yan
DOI: https://doi.org/10.2147/DDDT.S388932
2023-02-12
Abstract:Weiya Zeng, 1– 3 Yuan Fang, 1– 3 Suifen Mo, 1– 3 Caihong Shen, 1– 3 Huiling Yang, 1– 3 Guihua Luo, 1– 3 Luhua Xiao, 1– 3 Ruoting Zhan, 1– 3 Ping Yan 1– 3 1 College of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; 2 Key Laboratory of Chinese Medicinal Resources from Lingnan (Guangzhou University of Chinese Medicine), Ministry of Education, Guangzhou, People's Republic of China; 3 Joint Laboratory of Nation Engineering Research Center for the Pharmaceutics of Traditional Chinese Medicines, Guangzhou, People's Republic of China Correspondence: Ruoting Zhan; Ping Yan, Guangzhou University of Chinese Medicine, No. 232, Outer Ring East Road, Guangzhou, Guangdong, People's Republic of China, Tel/Fax +86 20-39358045, Email ; Purpose: Rubia cordifolia L. (RC) is a classic herbal medicine for the treatment of rheumatoid arthritis (RA) and has been used since ancient times. The ethanol extract of Rubia cordifolia L. (RCE) showed obvious anti-RA effects in our previous study. However, further potential mechanisms require more exploration. We aimed to investigate the mechanism of RCE for the treatment of RA by integrating metabolomics and network pharmacology in this study. Methods: An adjuvant-induced arthritis (AIA) rat model was established, and we evaluated the therapeutic effects of RCE. Metabolomics of serum and urine was used to identify the differential metabolites. Network pharmacology was applied to determine the key metabolites and potential targets. Finally, the potential targets and compounds of RCE were verified by molecular docking. Results: The results indicated that RCE suppressed foot swelling and alleviated joint damage and also had anti-inflammatory properties by inhibiting the expressions of tumor necrosis factor (TNF)-α, Interleukin (IL)-1β, prostaglandin E2 (PGE2), and P65. Ten and seven differential metabolites were found in the serum and urine, respectively, of rats. Six key targets, ie, phospholipase A2 group IIA (PLA2G2A), phospholipase A2 group X (PLA2G10), cytidine deaminase (CDA), uridine-cytidine kinase 2 (UCK2), charcot-leyden crystal galectin (CLC), and 5′,3′-nucleotidase, mitochondrial (NT5M), were discovered by network pharmacology and metabolite analysis and were found to be related to glycerophospholipid metabolism and pyrimidine metabolism. Molecular docking confirmed that the favorable compounds showed affinities with the key targets, including alizarin, 6-hydroxyrubiadin, ruberythric acid, and munjistin. Conclusion: This study revealed the underlying mechanisms of RCE and provided evidence that will allow researchers to further investigate the functions and components of RCE against RA. Keywords: inflammtion, AIA rats, molecular docking, chronic disease Rheumatoid arthritis (RA) is an autoimmune system disorder disease characterized by swollen joints, bone erosion and cartilage deterioration, 1 RA not only damages the joints but also the heart, kidneys, lungs, digestive system, eyes, skin, nervous system and other extra-articular organs. 2,3 The cause of RA is unknown, it is mainly related to the genetics, environment, and autoimmunity. 4,5 Clinical anti-RA drugs are divided into symptomatic treatment and disease modifying management. Symptomatic treatment including nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids (GCs), whose goal is to reduce inflammation and pain, while disease modifying drugs are mainly DMARDs, which aim to improve cartilage injury and joint deformity. 6,7 However, adverse effects and side effects can occur with the long-term use of GCs, NSAIDs, and DMARDs, such as gastrointestinal bleeding, hepatorenal toxicity, cardiovascular disease, and stomatitis, 8,9 thus, it is worth exploring effective and safe drugs. The latest research has revealed that several extracts and active compounds of traditional herbal medicines show potential anti-RA activity, such as flavonoids, phenolic acids, alkaloids, quinones, and triterpenes. 10 Currently, an increasing number of traditional medicines are being applied in clinics, such as Zishen Tongluo formula, 11 Ershiwuwei Lvxue pills, 12 Wenjinghuoluo prescriptions, 13 and Bawei Longzuan granules. 14 Rubia cordifolia L. (Rubiaceae, RC) is a sprawling plant, which prefer pleasantly cool and humidity environment and is distributed throughout Greece, Sudan, South-Africa, and Asia. 15 The aqueous leaf extract of RC showed antitumor, DNA-binding, antifungal, and antioxidant properties. 16 While the dry rh -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal